Metabolic syndrome in antiphospholipid syndrome versus rheumatoid arthritis and diabetes mellitus: Association with arterial thrombosis, cardiovascular risk biomarkers, physical activity, and coronary atherosclerotic plaques

Metabolic syndrome in antiphospholipid syndrome versus rheumatoid arthritis and diabetes mellitus: Association with arterial thrombosis, cardiovascular risk biomarkers, physical activity, and coronary atherosclerotic plaques

BackgroundCardiovascular disease (CVD) is the foremost cause of morbidity and deaths in antiphospholipid syndrome (APS), driven by thrombo-inflammation and atherothrombosis mechanisms. Metabolic syndrome (MetS) is a proinflammatory and prothrombotic state characterized by increased CVD risk. We aime...

Disgrifiad llawn

Manylion Llyfryddiaeth
Prif Awduron: Eleana Bolla, Nikolaos Tentolouris, Petros P. Sfikakis, Maria G. Tektonidou
Fformat: Erthygl
Iaith:English
Cyhoeddwyd: Frontiers Media S.A. 2023-01-01
Cyfres:Frontiers in Immunology
Pynciau:
antiphospholipid syndrome
metabolic syndrome
cardiovascular disease
atherosclerosis
thrombo-inflammation
cardiovascular risk factors
Mynediad Ar-lein:https://www.frontiersin.org/articles/10.3389/fimmu.2022.1077166/full

Rhyngrwyd

https://www.frontiersin.org/articles/10.3389/fimmu.2022.1077166/full

Eitemau Tebyg